Premium
Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation
Author(s) -
Lefrère J.J.,
Laperche S.,
RoudotThoraval F.
Publication year - 2008
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.2008.01050.x
Subject(s) - virology , in vivo , pathogen , hepatitis c virus , virus inactivation , virus , hepatitis a virus , hepatitis virus , medicine , immunology , biology , genetics
Being an orphan virus despite a large number of investigations, hepatitis G virus is a blood‐borne agent for which screening is not required in blood donations. The in vivo efficacy of pathogen inactivation methods could be assessed by the absence of hepatitis G virus markers after transfusion of pathogen‐inactivated blood products, in recipients susceptible to infection before the transfusion.